查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1403497

至 2030 年重症加护诊断市场预测：按产品、测试类型、最终用户和地区分類的全球分析

Critical Care Diagnostics Market Forecasts to 2030 - Global Analysis By Product (Cancer Markers Testing Kit, Fecal Occult Testing Kits, Cholesterol Test Strips and Other Products), Test Type, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球重症加护诊断市场规模为 12.9 亿美元，预计到 2030 年将达到 18.8 亿美元，预测期内复合年增长率为 5.5%。

重症加护诊断旨在准确、快速地评估患有危及生命的疾病、需要立即治疗的患者。该领域包括各种诊断程序和监测方法，旨在为医疗专业人员提供有关器官功能、血液气体和电解质等重要参数的最新资料。在这一领域，快速且准确的诊断设备在监测和评估重症患者、实现有针对性的干预以及改善患者整体治疗效果方面发挥着重要作用。

根据美国医学会的数据，美国在医疗保健上的支出为 4.3 兆美元，相当于每人 12,194 美元。同年卫生总支出约占国内生产毛额的18.3%。

提高诊断意识

随着世界各地的医疗保健系统认识到快速介入严重的重要性，人们越来越关注先进的诊断工具和技术。早期诊断使医疗保健专业人员能够提供有针对性和及时的干预措施，从而改善患者的预后并减少对医疗保健资源的整体需求。诊断技术的改进也推动了这一趋势，从而带来更快、更准确的测试方法。

发展中地区的可及性有限

全球重症加护诊断市场的一个主要障碍是新兴市场的可近性较低。这些地区经常面临诊断设施资源缺乏、技术纯熟劳工缺乏以及医疗基础设施不足等问题。结果，重症加护诊断的可近性和成本效益受到影响，阻碍了快速、准确的疾病诊断。然而，要规避这些限制并提高开发中国家重症患者诊断的可及性，解决这些问题的方法有很多，包括增加医疗基础设施投资和强化能力建设项目，需要付出努力。

POCT 解决方案的需求不断增长

对即时检测 (POCT) 解决方案日益增长的需求正在为全球重症监护诊断市场创造重大机会。在紧急医疗领域，快速、准确的诊断结果变得越来越重要。 POCT 帮助医疗专业人员及时做出有关病患照护的决策。这一趋势的推动因素是需要更快、更有效地诊断重症患者，以改善患者的治疗结果。此外，先进分子检测和携带式诊断设备等最尖端科技的引入也推动了市场成长。随着全球医疗保健系统优先考虑高效提供重症加护，对创新诊断解决方案的需求不断增加。

诊断技术日益复杂

开发尖端诊断技术的复杂性和成本不断增加，对全球重症患者诊断市场构成严重威胁。随着对更准确和更复杂的重症监护诊断的需求的增加，该行业面临挑战，包括与研发相关的成本、监管障碍以及对专业知识的需求。然而，医疗保健报销和政策条件的变化可能会影响市场扩张，给製造商带来挑战，并抑制新诊断技术的采用。

COVID-19 的影响：

COVID-19大流行导致诊断设备和设备的需求激增。重症加护诊断技术透过快速、准确检测的需求推动的创新和进步而取得了进展。分子诊断、影像解决方案和即时检测设备的研发成本正在增加。重症患者，导致人们更加重视重症患者诊断解决方案。

怀孕和不孕症检测套组领域预计将成为预测期内最大的市场。

妊娠和不孕症检测套组领域预计将快速成长。怀孕和不孕症检测套组套件部门专注于为测量和追踪与怀孕和不孕症相关的参数而创建的诊断设备。这些检测套组对于早期检测怀孕和不孕症教育至关重要。这些测试使用血液和尿液分析等各种技术，提供准确的结果，以便进行计划生育和及时干预。此外，自我监测趋势的增长以及生殖健康意识的提高推动了对这些套件的需求。

预计微生物学和传染病检查领域在预测期内的复合年增长率最高。

由于对引起感染疾病的微生物病原体的识别和分析，微生物学和传染病检查领域预计将出现良好的增长。这个重要的领域测试各种检体，如血液、尿液和组织样本，以检测细菌、病毒、真菌和寄生虫。利用聚合酶链反应 (PCR) 和免疫检测等先进的诊断技术，医疗保健专业人员可以快速、准确地诊断感染疾病。此外，分子技术和自动化的进步进一步提高了重症加护诊断中微生物和传染病检查检测的效率和准确性。

比最大的地区

由于慢性病患病率上升和先进的医疗保健系统，北美地区的重症加护诊断市场正在显着增长。呼吸系统疾病和心臟病等疾病的盛行率不断增加，增加了对重症加护诊断的需求。该地区对早期疾病检测和高医疗保健支出的重视正在推动重症加护诊断的成长。此外，北美深受强调及时诊断和治疗重要性的政府倡议和宣传宣传活动的影响。

复合年增长率最高的地区：

由于人口高龄化以及严重监护环境中对快速准确诊断测试的需求等多种因素，欧洲地区正在经历市场成长。已实施监管措施，确保重症加护诊断设备的品质、安全性和有效性，促进创新并推动区域成长。严格的核准流程和对高品质标准的遵守导致该行业的公司增加了研发投资。此外，在欧洲，我们继续与主要产业参与者和学术机构合作，为重症患者的诊断提供支援。

免费客製化服务

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场公司的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球重症加护诊断市场：依产品

  • 癌症标记检测套组
  • 大便潜血试验套件
  • 胆固醇试纸
  • 药物滥用检测套组
  • 妊娠和生育力检测套组
  • 心臟代谢监测套件
  • 传染病检查套件
  • 血糖监测套件
  • 其他产品

第六章全球重症加护诊断市场：依测试类型

  • 流式细胞仪
  • 血液学检查
  • 血液凝固检验
  • 微生物学和传染病检查
  • 免疫蛋白
  • 日常化学和特殊化学
  • 其他测试类型

第七章全球重症加护诊断市场：依最终用户分类

  • 手术室
  • 加护病房
  • 急诊室
  • 其他最终用户

第八章全球重症加护诊断市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东/非洲

第九章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十章 公司简介

  • Abbott Laboratories
  • Alere, Inc.
  • Bayer Healthcare AG
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • BioMerieux, Inc.
  • Bio-Rad Laboratories, Inc.
  • Biosensors Japan Co., Ltd.
  • Chembio Diagnostic Systems, Inc.
  • EKF Diagnostics Holdings PLC
  • Nanomix, Inc.
  • Nova Biomedical Corporation
  • Roche Diagnostics AG
  • Siemens Healthineers
  • Sysmex Corporation
Product Code: SMRC24722

According to Stratistics MRC, the Global Critical Care Diagnostics Market is accounted for $1.29 billion in 2023 and is expected to reach $1.88 billion by 2030 growing at a CAGR of 5.5% during the forecast period. Critical care diagnostics is devoted to assessing patients accurately and quickly who have life-threatening illnesses that frequently call for immediate treatment. This area of study includes a variety of diagnostic procedures and monitoring methods intended to give medical professionals access to up-to-date data on critical parameters like organ function, blood gases, and electrolytes. In this field, quick and accurate diagnostic instruments play a major role in monitoring and assessing critically ill patients, enabling focused interventions, and enhancing overall patient outcomes.

According to America Medical Association, the U.S. spent USD 4.3 trillion on healthcare, which equates to USD 12,194 per capita. The overall health spending was around 18.3% of the GDP in the same year.

Market Dynamics:

Driver:

Increased awareness on diagnosis

An increasing focus is being placed on advanced diagnostic tools and technologies as healthcare systems across the globe acknowledge the significance of prompt intervention in critical conditions. Early diagnosis improves patient outcomes and lessens the overall demand on healthcare resources by allowing medical professionals to launch focused, timely interventions. Improvements in diagnostic techniques are also driving this trend, resulting in the creation of testing methods that are faster and more accurate.

Restraint:

Limited accessibility in developing regions

A major barrier to the global critical care diagnostics market is the lack of accessibility in developing nations. These areas frequently struggle with issues like a lack of resources for diagnostic facilities, a shortage of skilled workers, and inadequate healthcare infrastructure. Consequently, there are compromises in the accessibility and cost-effectiveness of critical care diagnostics, impeding prompt and precise disease diagnosis. However, to get around this restriction and enhance the accessibility of critical care diagnostics in developing nations, efforts must be made to address these issues, such as through increased investment in healthcare infrastructure and focused capacity-building programs.

Opportunity:

Growing demand for POCT solutions

The increasing need for point-of-care testing (POCT) solutions presents a major opportunity in the global critical care diagnostics market. In critical care settings, there is a growing focus on quick and accurate diagnostic results. POCT helps medical professionals make timely decisions about patient care. In order to improve patient outcomes, this trend is motivated by the need to expedite critical care diagnostics and increase their efficiency. The market's growth is also aided by the uptake of cutting-edge technologies like sophisticated molecular testing and portable diagnostic devices. Innovative diagnostic solutions are in high demand as global healthcare systems prioritize providing critical care efficiently.

Threat:

Increasing complexity associated with diagnostic technologies

The growing complexity and expense of creating cutting-edge diagnostic technologies pose a serious threat to the global critical care diagnostics market. The industry faces difficulties with regard to costs associated with research and development, obstacles posed by regulations, and the requirement for specialized knowledge as the demand for more accurate and sophisticated critical care diagnostics increases. However, changing healthcare reimbursement and policy landscapes may have an effect on market expansion, posing challenges for manufacturers and impeding the uptake of novel diagnostic technologies.

COVID-19 Impact:

The COVID-19 pandemic has caused a sharp increase in demand for diagnostic instruments and equipment. Critical care diagnostics technology has advanced due to innovation and advancements driven by the need for fast and accurate testing. Research and development expenditures for molecular diagnostics, imaging solutions, and point-of-care testing devices have increased. A greater emphasis on critical care diagnostic solutions has resulted from the pandemic's emphasis on the significance of early and accurate diagnostics in the management of critically ill patients.

The pregnancy and fertility testing kits segment is expected to be the largest during the forecast period

The pregnancy and fertility testing kits segment is estimated to grow at a rapid pace. The pregnancy and fertility testing kits segment focuses on diagnostic instruments made to measure and track parameters related to pregnancy and fertility. These kits are essential for early pregnancy detection and for educating people about their fertility. These tests, which use different techniques like blood or urine analysis, yield precise results that allow for family planning and prompt intervention. Additionally, the demand for these kits has been driven by the rising trend of self-monitoring along with increased awareness of reproductive health.

The microbiology and infectious test segment is expected to have the highest CAGR during the forecast period

The microbiology and infectious test segment is expected to hold lucrative growth as it identifies and analyzes microbial pathogens responsible for infectious diseases. This crucial segment involves the examination of various specimens, such as blood, urine, and tissue samples, to detect bacteria, viruses, fungi, and parasites. Utilizing advanced diagnostic technologies like polymerase chain reaction (PCR) and immunoassays, healthcare professionals can rapidly and accurately diagnose infectious conditions. Additionally, the ongoing advancements in molecular techniques and automation further enhance the efficiency and precision of microbiological and infectious tests in critical care diagnostics.

Region with largest share:

The market for critical care diagnostics has grown substantially in the North American region as a result of rising rates of chronic illness and sophisticated healthcare systems. The need for critical care diagnostics has increased due to the growing prevalence of illnesses like respiratory and cardiac disorders. The growth of critical care diagnostics has been facilitated by the region's emphasis on early disease detection and high healthcare spending. Moreover, North America has also been deeply influenced by government initiatives and awareness campaigns that highlight the significance of prompt diagnosis and treatment.

Region with highest CAGR:

The European region has experienced growth in the market as a result of various factors, including population aging, need for quick and precise diagnostic testing in critical care settings. Regulatory measures have been implemented to ensure the quality, safety, and efficacy of critical care diagnostic devices, fostering innovation and driving regional growth. Stringent approval processes and adherence to high-quality standards have led to increased investment in research and development by companies in the sector. In addition, partnerships between major industry participants and academic institutions and support for critical care diagnostics continued in Europe.

Key players in the market:

Some of the key players in Critical Care Diagnostics market include Abbott Laboratories, Alere, Inc., Bayer Healthcare AG, Beckman Coulter, Inc., Becton, Dickinson and Company, BioMerieux, Inc., Bio-Rad Laboratories, Inc., Biosensors Japan Co., Ltd., Chembio Diagnostic Systems, Inc., EKF Diagnostics Holdings PLC, Nanomix, Inc., Nova Biomedical Corporation, Roche Diagnostics AG, Siemens Healthineers and Sysmex Corporation.

Key Developments:

In December 2023, Fujirebio Holdings, Inc. and Sysmex Corporation announced that they have signed an agreement for the mutual supply of reagent raw materials owned by both companies. The Agreement is based on a basic agreement on business collaboration in the field of immunoassay*1 which the two companies signed.

In March 2023, ABEC announced it will provide customized, large-scale bioprocess equipment, including a 14,500-liter total volume stainless steel fermenter and an 8,000 liter media preparation system to EKF Life Sciences, a division of EKF Diagnostics Holdings plc. The agreement provides EKF Life Sciences' South Bend, Indiana facility with the bioprocess equipment which will significantly expand EKF's production capacity of enzymes used in a variety of diagnostic and Life Science applications.

Products Covered:

  • Cancer Markers Testing Kit
  • Fecal Occult Testing Kits
  • Cholesterol Test Strips
  • Drugs Of Abuse Testing Kits
  • Pregnancy and Fertility Testing Kits
  • Cardiometabolic Monitoring Kits
  • Infectious Disease Testing Kits
  • Glucose Monitoring Kits
  • Other Products

Test Types Covered:

  • Flow Cytometry
  • Hematology Test
  • Coagulation Test
  • Microbiology and Infectious Test
  • Immunoprotein
  • Routine and Special Chemistry
  • Other Test Types

End Users Covered:

  • Operating Room
  • Intensive Care Unit
  • Emergency Room
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Critical Care Diagnostics Market, By Product

  • 5.1 Introduction
  • 5.2 Cancer Markers Testing Kit
  • 5.3 Fecal Occult Testing Kits
  • 5.4 Cholesterol Test Strips
  • 5.5 Drugs Of Abuse Testing Kits
  • 5.6 Pregnancy and Fertility Testing Kits
  • 5.7 Cardiometabolic Monitoring Kits
  • 5.8 Infectious Disease Testing Kits
  • 5.9 Glucose Monitoring Kits
  • 5.10 Other Products

6 Global Critical Care Diagnostics Market, By Test Type

  • 6.1 Introduction
  • 6.2 Flow Cytometry
  • 6.3 Hematology Test
  • 6.4 Coagulation Test
  • 6.5 Microbiology and Infectious Test
  • 6.6 Immunoprotein
  • 6.7 Routine and Special Chemistry
  • 6.8 Other Test Types

7 Global Critical Care Diagnostics Market, By End User

  • 7.1 Introduction
  • 7.2 Operating Room
  • 7.3 Intensive Care Unit
  • 7.4 Emergency Room
  • 7.5 Other End Users

8 Global Critical Care Diagnostics Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Abbott Laboratories
  • 10.2 Alere, Inc.
  • 10.3 Bayer Healthcare AG
  • 10.4 Beckman Coulter, Inc.
  • 10.5 Becton, Dickinson and Company
  • 10.6 BioMerieux, Inc.
  • 10.7 Bio-Rad Laboratories, Inc.
  • 10.8 Biosensors Japan Co., Ltd.
  • 10.9 Chembio Diagnostic Systems, Inc.
  • 10.10 EKF Diagnostics Holdings PLC
  • 10.11 Nanomix, Inc.
  • 10.12 Nova Biomedical Corporation
  • 10.13 Roche Diagnostics AG
  • 10.14 Siemens Healthineers
  • 10.15 Sysmex Corporation

List of Tables

  • Table 1 Global Critical Care Diagnostics Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Critical Care Diagnostics Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Critical Care Diagnostics Market Outlook, By Cancer Markers Testing Kit (2021-2030) ($MN)
  • Table 4 Global Critical Care Diagnostics Market Outlook, By Fecal Occult Testing Kits (2021-2030) ($MN)
  • Table 5 Global Critical Care Diagnostics Market Outlook, By Cholesterol Test Strips (2021-2030) ($MN)
  • Table 6 Global Critical Care Diagnostics Market Outlook, By Drugs Of Abuse Testing Kits (2021-2030) ($MN)
  • Table 7 Global Critical Care Diagnostics Market Outlook, By Pregnancy and Fertility Testing Kits (2021-2030) ($MN)
  • Table 8 Global Critical Care Diagnostics Market Outlook, By Cardiometabolic Monitoring Kits (2021-2030) ($MN)
  • Table 9 Global Critical Care Diagnostics Market Outlook, By Infectious Disease Testing Kits (2021-2030) ($MN)
  • Table 10 Global Critical Care Diagnostics Market Outlook, By Glucose Monitoring Kits (2021-2030) ($MN)
  • Table 11 Global Critical Care Diagnostics Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 12 Global Critical Care Diagnostics Market Outlook, By Test Type (2021-2030) ($MN)
  • Table 13 Global Critical Care Diagnostics Market Outlook, By Flow Cytometry (2021-2030) ($MN)
  • Table 14 Global Critical Care Diagnostics Market Outlook, By Hematology Test (2021-2030) ($MN)
  • Table 15 Global Critical Care Diagnostics Market Outlook, By Coagulation Test (2021-2030) ($MN)
  • Table 16 Global Critical Care Diagnostics Market Outlook, By Microbiology and Infectious Test (2021-2030) ($MN)
  • Table 17 Global Critical Care Diagnostics Market Outlook, By Immunoprotein (2021-2030) ($MN)
  • Table 18 Global Critical Care Diagnostics Market Outlook, By Routine and Special Chemistry (2021-2030) ($MN)
  • Table 19 Global Critical Care Diagnostics Market Outlook, By Other Test Types (2021-2030) ($MN)
  • Table 20 Global Critical Care Diagnostics Market Outlook, By End User (2021-2030) ($MN)
  • Table 21 Global Critical Care Diagnostics Market Outlook, By Operating Room (2021-2030) ($MN)
  • Table 22 Global Critical Care Diagnostics Market Outlook, By Intensive Care Unit (2021-2030) ($MN)
  • Table 23 Global Critical Care Diagnostics Market Outlook, By Emergency Room (2021-2030) ($MN)
  • Table 24 Global Critical Care Diagnostics Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 25 North America Critical Care Diagnostics Market Outlook, By Country (2021-2030) ($MN)
  • Table 26 North America Critical Care Diagnostics Market Outlook, By Product (2021-2030) ($MN)
  • Table 27 North America Critical Care Diagnostics Market Outlook, By Cancer Markers Testing Kit (2021-2030) ($MN)
  • Table 28 North America Critical Care Diagnostics Market Outlook, By Fecal Occult Testing Kits (2021-2030) ($MN)
  • Table 29 North America Critical Care Diagnostics Market Outlook, By Cholesterol Test Strips (2021-2030) ($MN)
  • Table 30 North America Critical Care Diagnostics Market Outlook, By Drugs Of Abuse Testing Kits (2021-2030) ($MN)
  • Table 31 North America Critical Care Diagnostics Market Outlook, By Pregnancy and Fertility Testing Kits (2021-2030) ($MN)
  • Table 32 North America Critical Care Diagnostics Market Outlook, By Cardiometabolic Monitoring Kits (2021-2030) ($MN)
  • Table 33 North America Critical Care Diagnostics Market Outlook, By Infectious Disease Testing Kits (2021-2030) ($MN)
  • Table 34 North America Critical Care Diagnostics Market Outlook, By Glucose Monitoring Kits (2021-2030) ($MN)
  • Table 35 North America Critical Care Diagnostics Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 36 North America Critical Care Diagnostics Market Outlook, By Test Type (2021-2030) ($MN)
  • Table 37 North America Critical Care Diagnostics Market Outlook, By Flow Cytometry (2021-2030) ($MN)
  • Table 38 North America Critical Care Diagnostics Market Outlook, By Hematology Test (2021-2030) ($MN)
  • Table 39 North America Critical Care Diagnostics Market Outlook, By Coagulation Test (2021-2030) ($MN)
  • Table 40 North America Critical Care Diagnostics Market Outlook, By Microbiology and Infectious Test (2021-2030) ($MN)
  • Table 41 North America Critical Care Diagnostics Market Outlook, By Immunoprotein (2021-2030) ($MN)
  • Table 42 North America Critical Care Diagnostics Market Outlook, By Routine and Special Chemistry (2021-2030) ($MN)
  • Table 43 North America Critical Care Diagnostics Market Outlook, By Other Test Types (2021-2030) ($MN)
  • Table 44 North America Critical Care Diagnostics Market Outlook, By End User (2021-2030) ($MN)
  • Table 45 North America Critical Care Diagnostics Market Outlook, By Operating Room (2021-2030) ($MN)
  • Table 46 North America Critical Care Diagnostics Market Outlook, By Intensive Care Unit (2021-2030) ($MN)
  • Table 47 North America Critical Care Diagnostics Market Outlook, By Emergency Room (2021-2030) ($MN)
  • Table 48 North America Critical Care Diagnostics Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 49 Europe Critical Care Diagnostics Market Outlook, By Country (2021-2030) ($MN)
  • Table 50 Europe Critical Care Diagnostics Market Outlook, By Product (2021-2030) ($MN)
  • Table 51 Europe Critical Care Diagnostics Market Outlook, By Cancer Markers Testing Kit (2021-2030) ($MN)
  • Table 52 Europe Critical Care Diagnostics Market Outlook, By Fecal Occult Testing Kits (2021-2030) ($MN)
  • Table 53 Europe Critical Care Diagnostics Market Outlook, By Cholesterol Test Strips (2021-2030) ($MN)
  • Table 54 Europe Critical Care Diagnostics Market Outlook, By Drugs Of Abuse Testing Kits (2021-2030) ($MN)
  • Table 55 Europe Critical Care Diagnostics Market Outlook, By Pregnancy and Fertility Testing Kits (2021-2030) ($MN)
  • Table 56 Europe Critical Care Diagnostics Market Outlook, By Cardiometabolic Monitoring Kits (2021-2030) ($MN)
  • Table 57 Europe Critical Care Diagnostics Market Outlook, By Infectious Disease Testing Kits (2021-2030) ($MN)
  • Table 58 Europe Critical Care Diagnostics Market Outlook, By Glucose Monitoring Kits (2021-2030) ($MN)
  • Table 59 Europe Critical Care Diagnostics Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 60 Europe Critical Care Diagnostics Market Outlook, By Test Type (2021-2030) ($MN)
  • Table 61 Europe Critical Care Diagnostics Market Outlook, By Flow Cytometry (2021-2030) ($MN)
  • Table 62 Europe Critical Care Diagnostics Market Outlook, By Hematology Test (2021-2030) ($MN)
  • Table 63 Europe Critical Care Diagnostics Market Outlook, By Coagulation Test (2021-2030) ($MN)
  • Table 64 Europe Critical Care Diagnostics Market Outlook, By Microbiology and Infectious Test (2021-2030) ($MN)
  • Table 65 Europe Critical Care Diagnostics Market Outlook, By Immunoprotein (2021-2030) ($MN)
  • Table 66 Europe Critical Care Diagnostics Market Outlook, By Routine and Special Chemistry (2021-2030) ($MN)
  • Table 67 Europe Critical Care Diagnostics Market Outlook, By Other Test Types (2021-2030) ($MN)
  • Table 68 Europe Critical Care Diagnostics Market Outlook, By End User (2021-2030) ($MN)
  • Table 69 Europe Critical Care Diagnostics Market Outlook, By Operating Room (2021-2030) ($MN)
  • Table 70 Europe Critical Care Diagnostics Market Outlook, By Intensive Care Unit (2021-2030) ($MN)
  • Table 71 Europe Critical Care Diagnostics Market Outlook, By Emergency Room (2021-2030) ($MN)
  • Table 72 Europe Critical Care Diagnostics Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 73 Asia Pacific Critical Care Diagnostics Market Outlook, By Country (2021-2030) ($MN)
  • Table 74 Asia Pacific Critical Care Diagnostics Market Outlook, By Product (2021-2030) ($MN)
  • Table 75 Asia Pacific Critical Care Diagnostics Market Outlook, By Cancer Markers Testing Kit (2021-2030) ($MN)
  • Table 76 Asia Pacific Critical Care Diagnostics Market Outlook, By Fecal Occult Testing Kits (2021-2030) ($MN)
  • Table 77 Asia Pacific Critical Care Diagnostics Market Outlook, By Cholesterol Test Strips (2021-2030) ($MN)
  • Table 78 Asia Pacific Critical Care Diagnostics Market Outlook, By Drugs Of Abuse Testing Kits (2021-2030) ($MN)
  • Table 79 Asia Pacific Critical Care Diagnostics Market Outlook, By Pregnancy and Fertility Testing Kits (2021-2030) ($MN)
  • Table 80 Asia Pacific Critical Care Diagnostics Market Outlook, By Cardiometabolic Monitoring Kits (2021-2030) ($MN)
  • Table 81 Asia Pacific Critical Care Diagnostics Market Outlook, By Infectious Disease Testing Kits (2021-2030) ($MN)
  • Table 82 Asia Pacific Critical Care Diagnostics Market Outlook, By Glucose Monitoring Kits (2021-2030) ($MN)
  • Table 83 Asia Pacific Critical Care Diagnostics Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 84 Asia Pacific Critical Care Diagnostics Market Outlook, By Test Type (2021-2030) ($MN)
  • Table 85 Asia Pacific Critical Care Diagnostics Market Outlook, By Flow Cytometry (2021-2030) ($MN)
  • Table 86 Asia Pacific Critical Care Diagnostics Market Outlook, By Hematology Test (2021-2030) ($MN)
  • Table 87 Asia Pacific Critical Care Diagnostics Market Outlook, By Coagulation Test (2021-2030) ($MN)
  • Table 88 Asia Pacific Critical Care Diagnostics Market Outlook, By Microbiology and Infectious Test (2021-2030) ($MN)
  • Table 89 Asia Pacific Critical Care Diagnostics Market Outlook, By Immunoprotein (2021-2030) ($MN)
  • Table 90 Asia Pacific Critical Care Diagnostics Market Outlook, By Routine and Special Chemistry (2021-2030) ($MN)
  • Table 91 Asia Pacific Critical Care Diagnostics Market Outlook, By Other Test Types (2021-2030) ($MN)
  • Table 92 Asia Pacific Critical Care Diagnostics Market Outlook, By End User (2021-2030) ($MN)
  • Table 93 Asia Pacific Critical Care Diagnostics Market Outlook, By Operating Room (2021-2030) ($MN)
  • Table 94 Asia Pacific Critical Care Diagnostics Market Outlook, By Intensive Care Unit (2021-2030) ($MN)
  • Table 95 Asia Pacific Critical Care Diagnostics Market Outlook, By Emergency Room (2021-2030) ($MN)
  • Table 96 Asia Pacific Critical Care Diagnostics Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 97 South America Critical Care Diagnostics Market Outlook, By Country (2021-2030) ($MN)
  • Table 98 South America Critical Care Diagnostics Market Outlook, By Product (2021-2030) ($MN)
  • Table 99 South America Critical Care Diagnostics Market Outlook, By Cancer Markers Testing Kit (2021-2030) ($MN)
  • Table 100 South America Critical Care Diagnostics Market Outlook, By Fecal Occult Testing Kits (2021-2030) ($MN)
  • Table 101 South America Critical Care Diagnostics Market Outlook, By Cholesterol Test Strips (2021-2030) ($MN)
  • Table 102 South America Critical Care Diagnostics Market Outlook, By Drugs Of Abuse Testing Kits (2021-2030) ($MN)
  • Table 103 South America Critical Care Diagnostics Market Outlook, By Pregnancy and Fertility Testing Kits (2021-2030) ($MN)
  • Table 104 South America Critical Care Diagnostics Market Outlook, By Cardiometabolic Monitoring Kits (2021-2030) ($MN)
  • Table 105 South America Critical Care Diagnostics Market Outlook, By Infectious Disease Testing Kits (2021-2030) ($MN)
  • Table 106 South America Critical Care Diagnostics Market Outlook, By Glucose Monitoring Kits (2021-2030) ($MN)
  • Table 107 South America Critical Care Diagnostics Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 108 South America Critical Care Diagnostics Market Outlook, By Test Type (2021-2030) ($MN)
  • Table 109 South America Critical Care Diagnostics Market Outlook, By Flow Cytometry (2021-2030) ($MN)
  • Table 110 South America Critical Care Diagnostics Market Outlook, By Hematology Test (2021-2030) ($MN)
  • Table 111 South America Critical Care Diagnostics Market Outlook, By Coagulation Test (2021-2030) ($MN)
  • Table 112 South America Critical Care Diagnostics Market Outlook, By Microbiology and Infectious Test (2021-2030) ($MN)
  • Table 113 South America Critical Care Diagnostics Market Outlook, By Immunoprotein (2021-2030) ($MN)
  • Table 114 South America Critical Care Diagnostics Market Outlook, By Routine and Special Chemistry (2021-2030) ($MN)
  • Table 115 South America Critical Care Diagnostics Market Outlook, By Other Test Types (2021-2030) ($MN)
  • Table 116 South America Critical Care Diagnostics Market Outlook, By End User (2021-2030) ($MN)
  • Table 117 South America Critical Care Diagnostics Market Outlook, By Operating Room (2021-2030) ($MN)
  • Table 118 South America Critical Care Diagnostics Market Outlook, By Intensive Care Unit (2021-2030) ($MN)
  • Table 119 South America Critical Care Diagnostics Market Outlook, By Emergency Room (2021-2030) ($MN)
  • Table 120 South America Critical Care Diagnostics Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 121 Middle East & Africa Critical Care Diagnostics Market Outlook, By Country (2021-2030) ($MN)
  • Table 122 Middle East & Africa Critical Care Diagnostics Market Outlook, By Product (2021-2030) ($MN)
  • Table 123 Middle East & Africa Critical Care Diagnostics Market Outlook, By Cancer Markers Testing Kit (2021-2030) ($MN)
  • Table 124 Middle East & Africa Critical Care Diagnostics Market Outlook, By Fecal Occult Testing Kits (2021-2030) ($MN)
  • Table 125 Middle East & Africa Critical Care Diagnostics Market Outlook, By Cholesterol Test Strips (2021-2030) ($MN)
  • Table 126 Middle East & Africa Critical Care Diagnostics Market Outlook, By Drugs Of Abuse Testing Kits (2021-2030) ($MN)
  • Table 127 Middle East & Africa Critical Care Diagnostics Market Outlook, By Pregnancy and Fertility Testing Kits (2021-2030) ($MN)
  • Table 128 Middle East & Africa Critical Care Diagnostics Market Outlook, By Cardiometabolic Monitoring Kits (2021-2030) ($MN)
  • Table 129 Middle East & Africa Critical Care Diagnostics Market Outlook, By Infectious Disease Testing Kits (2021-2030) ($MN)
  • Table 130 Middle East & Africa Critical Care Diagnostics Market Outlook, By Glucose Monitoring Kits (2021-2030) ($MN)
  • Table 131 Middle East & Africa Critical Care Diagnostics Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 132 Middle East & Africa Critical Care Diagnostics Market Outlook, By Test Type (2021-2030) ($MN)
  • Table 133 Middle East & Africa Critical Care Diagnostics Market Outlook, By Flow Cytometry (2021-2030) ($MN)
  • Table 134 Middle East & Africa Critical Care Diagnostics Market Outlook, By Hematology Test (2021-2030) ($MN)
  • Table 135 Middle East & Africa Critical Care Diagnostics Market Outlook, By Coagulation Test (2021-2030) ($MN)
  • Table 136 Middle East & Africa Critical Care Diagnostics Market Outlook, By Microbiology and Infectious Test (2021-2030) ($MN)
  • Table 137 Middle East & Africa Critical Care Diagnostics Market Outlook, By Immunoprotein (2021-2030) ($MN)
  • Table 138 Middle East & Africa Critical Care Diagnostics Market Outlook, By Routine and Special Chemistry (2021-2030) ($MN)
  • Table 139 Middle East & Africa Critical Care Diagnostics Market Outlook, By Other Test Types (2021-2030) ($MN)
  • Table 140 Middle East & Africa Critical Care Diagnostics Market Outlook, By End User (2021-2030) ($MN)
  • Table 141 Middle East & Africa Critical Care Diagnostics Market Outlook, By Operating Room (2021-2030) ($MN)
  • Table 142 Middle East & Africa Critical Care Diagnostics Market Outlook, By Intensive Care Unit (2021-2030) ($MN)
  • Table 143 Middle East & Africa Critical Care Diagnostics Market Outlook, By Emergency Room (2021-2030) ($MN)
  • Table 144 Middle East & Africa Critical Care Diagnostics Market Outlook, By Other End Users (2021-2030) ($MN)